COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,757 Articles (22,943 medRxiv, 8,814 bioRxiv)

Most recent first Previous |  Page 353: Articles 3521-3530  | Next

The spectrum of non-fatal immune-related adverse events following COVID-19 vaccination: The population-based cohort study in Seoul, South Korea
Suh, J. H., Kim, H. J., Kim, M.-H., Choi, M. G., Chun, E. M.
10.1101/2023.11.15.23298566 — Posted: 2023-11-22
Correlation between COVID-19 vaccination and inflammatory musculoskeletal disorders
Park, Y. H., Kim, M. H., Choi, M. G., Chun, E. M.
10.1101/2023.11.14.23298544 — Posted: 2023-11-22
Public Health and Social Measures (PHSM) interventions to control COVID-19: A Protocol for an Overview of Systematic Reviews
Fadlallah, R., El-Jardali, F., Bou Karroum, L., Kalach, N., Hoteit, R., Aoun, A., Al-Hakim, L., Verdugo-Paiva, F., Rada, G., Fretheim, A., Lewin, S., Ludolph, R., Akl, E.
10.1101/2023.11.21.23298387 — Posted: 2023-11-22
Nationwide SARS-CoV-2 Seroprevalence Trends in the Netherlands in the Variant of Concern Era, 2021-2022: an Ongoing Prospective Cohort Study
Vos, E. R. A., van Hagen, C. C. E., Wong, D., Smits, G., Kuijer, M., Wijmenga-Monsuur, A. J., Kaczorowska, J., van Binnendijk, R. S., van der Klis, F. R. M., den Hartog, G., de Melker, H. E.
10.1101/2023.11.22.23298889 — Posted: 2023-11-22
CLUSTER ANALYSIS IDENTIFIES LONG COVID SUBTYPES IN BELGIAN PATIENTS
Mfouth Kemajou, P., Besse-Hammer, T., Lebouc, C., Coppieters, Y.
10.1101/2023.11.22.23298807 — Posted: 2023-11-22
Recovery of Neurophysiological Measures in Post-COVID Fatigue - a 12-month Longitudinal Follow-up Study
Maffitt, N. J., Germann, M., Baker, A. M., Baker, M. R., Baker, S. N., Soteropoulos, D. S.
10.1101/2023.11.22.23298846 — Posted: 2023-11-22
SARS-CoV-2 infects neurons, astrocytes, choroid plexus epithelial cells and pericytes of the human central nervous system
Haverty, R., McCormack, J., Evans, C., Purves, K., O'Reilly, S., Gautier, V. W., Rochfort, K., Fabre, A., Fletcher, N.
10.1101/2023.11.21.568132 — Posted: 2023-11-22
Modulation of Biophysical Properties of Nucleocapsid Protein in the Mutant Spectrum of SARS-CoV-2
Nguyen, A., Zhao, H., Myagmarsuren, D., Srinivasan, S., Wu, D., Chen, J., Piszczek, G., Schuck, P.
10.1101/2023.11.21.568093 — Posted: 2023-11-22
Seasonal Human Coronaviruses OC43, 229E, and NL63 Induce Cell Surface Modulation of Entry Receptors and Display Host Cell-Specific Viral Replication Kinetics
Siragam, V., Maltseva, M., Castonguay, N., Galipeau, Y., Srinivasan, M. M., Soto, J. H., Dankar, S., Langlois, M.-A.
10.1101/2023.11.20.567923 — Posted: 2023-11-22
Association Between COVID-19 During Pregnancy and Preterm Birth by Trimester of Infection: A Retrospective Cohort Study Using Longitudinal Social Media Data
Klein, A. Z., Kunatharaju, S., Golder, S., Levine, L. D., Figueiredo, J. C., Gonzalez-Hernandez, G.
10.1101/2023.11.17.23298696 — Posted: 2023-11-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).